Meeting ReportOncology: Basic, Translational & Therapy: Radiopharmaceutical Therapy
177 Lu-EDTMP for bone pain palliation in metastatic prostate and breast cancer: A phase II trial
Xingdang Liu, Congjin Liu, Hongyu Li, Xueqin Xiang, Zhifu Luo, Yuankai Wang and John Zaknun
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1752;
Xingdang Liu
1Department of Nuclear Medicine, Hua Shan Hospital, Fudan University, Shanghai, China
Congjin Liu
1Department of Nuclear Medicine, Hua Shan Hospital, Fudan University, Shanghai, China
Hongyu Li
2Department of Isotope, China Institute of Atomic Energy, Beijing, China
Xueqin Xiang
2Department of Isotope, China Institute of Atomic Energy, Beijing, China
Zhifu Luo
2Department of Isotope, China Institute of Atomic Energy, Beijing, China
Yuankai Wang
1Department of Nuclear Medicine, Hua Shan Hospital, Fudan University, Shanghai, China
John Zaknun
3Nuclear Medicine Section, Division of Human Health, IAEA, Vienna, Austria

Article Figures & Data
Figures
Table 1. Observed efficacy of 177Lu-EDTMP during 3 months following up
n:patients number;wk:week
In this issue
177 Lu-EDTMP for bone pain palliation in metastatic prostate and breast cancer: A phase II trial
Xingdang Liu, Congjin Liu, Hongyu Li, Xueqin Xiang, Zhifu Luo, Yuankai Wang, John Zaknun
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1752;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.